Clinical Trial Update: Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trials exploring Boron Neutron Capture Therapy (BNCT) for locally recurrent head and neck cancer have completed Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Boron neutron capture therapy (BNCT) (BNCT)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED